Schonfeld Strategic Advisors LLC Aldeyra Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $211,430 - $363,864	36,643 New	36,643 $363,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $100,800 - $277,344	-28,800 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$7.94 - $11.31 $17,420 - $24,814	-2,194 Reduced 7.08%	28,800 $253,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $162,738 - $231,481	15,588 Added 101.18%	30,994 $351,000
Q1 2021 May 17, 2021	SELL	$6.53 - $14.42 $119,159 - $263,136	-18,248 Reduced 54.22%	15,406 $182,000
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $469,754 - $605,245	-74,446 Reduced 68.87%	33,654 $232,000
Q3 2020 Nov 16, 2020	SELL	$4.0 - $7.53 $118,000 - $222,135	-29,500 Reduced 21.44%	108,100 $1,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $5.05 $271,072 - $694,880	137,600 New	137,600 $574,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $278M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.